In biotechs , Chinook Therapeutics , Eric Dobmeier , Health/Life Sciences , Kidney disease , Seattle Genetics , startups , Technology NEWS , Vancouver B.C. , Venture Capital
Canadian biotech company Chinook Therapeutics raises $65M for rare kidney disease therapies – GeekWire
Chinook Therapeutics CEO Eric Dobmeier. (Chinook Photo) Chinook Therapeutics, a Vancouver, B.C.-based biotech company creating targeted therapies for kidney.